Nifty
Sensex
:
:
11661.85
39298.38
75.50 (0.65%)
246.32 (0.63%)

Pharmaceuticals & Drugs

Rating :
61/99  (View)

BSE: 530239 | NSE: SUVEN

280.55
15.75 (5.95%)
18-Oct-2019 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  263.10
  •  284.05
  •  262.30
  •  264.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  366274
  •  1027.58
  •  304.40
  •  182.70

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,570.27
  • 21.20
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,594.71
  • 0.53%
  • 3.40

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 60.00%
  • 3.50%
  • 24.61%
  • FII
  • DII
  • Others
  • 0.16%
  • 2.15%
  • 9.58%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.77
  • 4.96
  • 6.87

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 32.67
  • 7.33
  • 6.55

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 35.87
  • 6.65
  • 6.72

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.48
  • 21.15
  • 19.41

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.45
  • 4.01
  • 3.21

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.21
  • 14.58
  • 12.23

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Net Sales
198.99
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
139.54
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
59.44
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
29.87%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
3.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
1.69
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
5.55
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
55.21
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
29.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
26.21
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
13.17%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
2.06
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 08
Mar 07
Mar 06
Mar 05
Net Sales
-
663.50
625.26
543.53
499.52
520.86
117.28
111.92
88.08
63.62
Net Sales Growth
-
6.12%
15.04%
8.81%
-4.10%
344.12%
4.79%
27.07%
38.45%
 
Cost Of Goods Sold
-
170.20
152.17
147.06
162.64
177.61
44.18
42.04
30.66
19.80
Gross Profit
-
493.31
473.09
396.47
336.88
343.25
73.10
69.88
57.42
43.83
GP Margin
-
74.35%
75.66%
72.94%
67.44%
65.90%
62.33%
62.44%
65.19%
68.89%
Total Expenditure
-
499.52
423.61
414.46
398.18
361.40
104.61
95.57
77.29
55.10
Power & Fuel Cost
-
37.43
33.56
31.50
29.32
28.04
7.95
6.34
5.77
5.13
% Of Sales
-
5.64%
5.37%
5.80%
5.87%
5.38%
6.78%
5.66%
6.55%
8.06%
Employee Cost
-
66.12
61.27
52.17
35.64
31.75
12.25
9.53
7.37
6.25
% Of Sales
-
9.97%
9.80%
9.60%
7.13%
6.10%
10.45%
8.52%
8.37%
9.82%
Manufacturing Exp.
-
183.36
144.07
153.86
139.49
95.91
29.74
27.89
25.17
16.36
% Of Sales
-
27.64%
23.04%
28.31%
27.92%
18.41%
25.36%
24.92%
28.58%
25.72%
General & Admin Exp.
-
24.21
20.66
19.45
22.48
20.14
8.38
7.53
5.85
5.27
% Of Sales
-
3.65%
3.30%
3.58%
4.50%
3.87%
7.15%
6.73%
6.64%
8.28%
Selling & Distn. Exp.
-
11.61
8.57
7.46
6.73
5.17
2.06
2.15
1.58
2.17
% Of Sales
-
1.75%
1.37%
1.37%
1.35%
0.99%
1.76%
1.92%
1.79%
3.41%
Miscellaneous Exp.
-
6.59
3.31
2.95
1.88
2.77
0.05
0.10
0.88
0.12
% Of Sales
-
0.99%
0.53%
0.54%
0.38%
0.53%
0.04%
0.09%
1.00%
0.19%
EBITDA
-
163.98
201.65
129.07
101.34
159.46
12.67
16.35
10.79
8.52
EBITDA Margin
-
24.71%
32.25%
23.75%
20.29%
30.61%
10.80%
14.61%
12.25%
13.39%
Other Income
-
24.23
23.27
21.09
19.62
8.58
3.18
1.46
0.82
1.54
Interest
-
3.77
4.63
5.68
5.88
4.71
5.06
3.03
1.65
0.82
Depreciation
-
25.69
24.76
21.41
17.50
11.78
4.44
4.01
3.46
3.23
PBT
-
158.74
195.53
123.07
97.58
151.55
6.36
10.76
6.49
6.01
Tax
-
71.80
71.84
35.88
25.74
42.80
-1.99
-0.51
0.11
3.61
Tax Rate
-
45.23%
36.74%
29.15%
26.38%
28.24%
-31.29%
-4.74%
1.69%
60.07%
PAT
-
86.94
123.69
87.19
71.85
108.75
8.35
11.26
6.39
2.41
PAT before Minority Interest
-
86.94
123.69
87.19
71.85
108.75
8.35
11.26
6.39
2.41
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
13.10%
19.78%
16.04%
14.38%
20.88%
7.12%
10.06%
7.25%
3.79%
PAT Growth
-
-29.71%
41.86%
21.35%
-33.93%
1202.40%
-25.84%
76.21%
165.15%
 
Unadjusted EPS
-
6.83
9.72
6.84
5.61
9.04
0.72
3.91
2.55
0.96

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 08
Mar 07
Mar 06
Mar 05
Shareholder's Funds
830.99
767.41
667.00
595.28
559.31
106.39
101.52
90.21
81.18
Share Capital
12.73
12.73
12.73
12.73
12.73
11.57
5.76
5.00
5.00
Total Reserves
818.27
754.68
654.27
582.56
546.59
94.82
95.76
85.21
76.18
Non-Current Liabilities
58.88
30.20
28.21
40.54
86.43
57.06
46.78
30.83
33.03
Secured Loans
0.00
0.25
22.65
37.08
55.09
54.62
41.49
23.68
19.81
Unsecured Loans
1.78
1.98
3.29
4.56
6.36
0.00
0.00
0.00
0.00
Long Term Provisions
7.43
3.69
2.84
2.39
2.27
0.00
0.00
0.00
0.00
Current Liabilities
299.31
225.83
208.05
210.62
127.39
35.08
24.95
21.98
21.55
Trade Payables
60.66
56.82
37.94
35.60
43.89
20.14
11.87
11.63
11.97
Other Current Liabilities
50.76
29.43
46.14
48.18
42.45
0.63
1.06
0.29
0.27
Short Term Borrowings
35.30
30.57
30.49
24.16
28.24
0.00
0.00
0.00
0.00
Short Term Provisions
152.60
109.01
93.49
102.68
12.81
14.32
12.02
10.07
9.31
Total Liabilities
1,189.18
1,023.44
903.26
846.44
773.13
198.53
173.25
143.02
135.76
Net Block
293.25
307.73
305.72
305.35
171.95
109.77
95.62
82.77
74.14
Gross Block
386.89
375.68
348.92
325.15
290.52
141.20
120.47
101.64
88.59
Accumulated Depreciation
93.64
67.95
43.19
19.80
118.57
31.43
24.86
18.87
14.45
Non Current Assets
415.67
349.61
322.10
318.79
291.31
115.72
105.60
89.53
84.55
Capital Work in Progress
111.09
24.74
9.72
7.20
107.01
3.66
5.02
2.67
3.31
Non Current Investment
0.07
0.07
0.07
0.07
0.00
2.29
4.96
4.09
7.09
Long Term Loans & Adv.
11.04
16.86
6.39
6.16
10.89
0.00
0.00
0.00
0.00
Other Non Current Assets
0.22
0.20
0.20
0.00
1.46
0.00
0.00
0.00
0.00
Current Assets
773.52
673.83
581.16
527.66
476.98
82.79
67.60
53.43
51.14
Current Investments
229.99
278.73
300.89
0.05
0.04
0.00
0.00
0.00
0.00
Inventories
157.10
139.47
92.51
83.46
81.81
24.40
22.90
22.74
19.31
Sundry Debtors
150.15
61.54
45.83
53.56
40.17
35.59
16.14
14.99
18.62
Cash & Bank
13.58
28.22
9.17
241.40
279.69
3.04
9.78
1.37
2.57
Other Current Assets
222.71
50.35
32.89
40.22
75.28
19.77
18.79
14.33
10.63
Short Term Loans & Adv.
159.01
115.53
99.87
108.96
34.06
14.93
14.33
9.70
8.81
Net Current Assets
474.21
448.00
373.11
317.04
349.59
47.71
42.65
31.45
29.58
Total Assets
1,189.19
1,023.44
903.26
846.45
773.14
198.53
173.24
143.02
135.78

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 08
Mar 07
Mar 06
Mar 05
Cash From Operating Activity
35.55
69.94
109.17
67.50
3.94
16.24
5.51
2.11
PBT
158.74
195.53
123.07
97.58
6.36
10.76
6.49
5.79
Adjustment
8.12
10.32
12.91
10.98
11.22
6.54
6.56
3.97
Changes in Working Capital
-84.59
-92.37
7.90
-14.36
-12.96
0.46
-6.52
-6.95
Cash after chg. in Working capital
82.27
113.47
143.88
94.20
4.63
17.75
6.54
2.81
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-46.72
-43.54
-34.71
-26.70
-0.69
-1.51
-1.03
-0.70
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-27.86
-0.61
-310.64
-38.63
-16.20
-20.46
-9.45
-4.11
Net Fixed Assets
-97.56
-41.78
-26.29
-187.49
-19.37
-21.18
-13.51
Net Investments
14.60
-15.06
-342.87
-14.91
2.67
-0.87
4.00
Others
55.10
56.23
58.52
163.77
0.50
1.59
0.06
Cash from Financing Activity
-22.51
-52.07
-30.39
-68.07
5.52
12.62
2.73
-7.51
Net Cash Inflow / Outflow
-14.82
17.26
-231.86
-39.20
-6.74
8.40
-1.20
-9.51
Opening Cash & Equivalents
25.95
8.69
240.55
279.75
9.78
1.37
2.57
12.09
Closing Cash & Equivalent
11.13
25.95
8.69
240.55
3.04
9.78
1.37
2.57

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 08
Mar 07
Mar 06
Mar 05
Mar 04
Book Value (Rs.)
65.29
60.29
52.40
46.77
43.56
9.19
35.21
9.01
8.11
8.16
ROA
7.86%
12.84%
9.97%
8.87%
22.38%
4.49%
7.12%
4.58%
1.82%
4.11%
ROE
10.88%
17.25%
13.81%
12.50%
32.91%
8.04%
11.76%
7.46%
2.96%
6.49%
ROCE
19.46%
26.01%
18.19%
15.43%
37.93%
7.51%
10.74%
7.59%
6.73%
8.95%
Fixed Asset Turnover
1.74
1.73
1.62
1.63
2.42
0.92
1.02
0.95
0.80
0.68
Receivable days
58.22
31.34
33.32
34.19
26.51
78.68
50.16
68.08
82.03
76.64
Inventory Days
81.57
67.71
58.98
60.29
37.16
71.95
73.54
85.16
87.39
85.28
Payable days
43.04
38.79
33.17
35.72
32.74
57.23
45.77
52.98
65.92
70.34
Cash Conversion Cycle
96.75
60.26
59.13
58.77
30.93
93.40
77.93
100.27
103.49
91.59
Total Debt/Equity
0.05
0.04
0.11
0.14
0.20
0.51
0.41
0.26
0.24
0.25
Interest Cover
43.06
43.25
22.65
17.61
33.18
2.26
4.55
4.93
8.30
11.60

News Update


  • Suven declares dose administration of 1st patient in Phase 2A clinical trial of SUVN G-3031
    25th Sep 2019, 12:12 PM

    The clinical development program being executed through Suven Neurosciences, Inc., a Delaware Company in USA, wholly owned subsidiary of Suven Life Sciences

    Read More
  • Suven Life Sciences - Quarterly Results
    14th Aug 2019, 13:09 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.